Back to top
more

Integer Holdings (ITGR)

(Delayed Data from NYSE)

$102.69 USD

102.69
421,572

-0.38 (-0.37%)

Updated Sep 17, 2025 04:00 PM ET

After-Market: $102.72 +0.03 (0.03%) 5:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

ITGR vs. SONVY: Which Stock Is the Better Value Option?

by Zacks Equity Research

ITGR vs. SONVY: Which Stock Is the Better Value Option?

Zacks Equity Research

Are Investors Undervaluing Integer Holdings (ITGR) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Urmimala Biswas headshot

3 Top Medical Instruments Stocks Defying Tariff Pressure With GenAI

by Urmimala Biswas

Teleflex, Integer Holdings and Inogen are defying tariff and supply chain headwinds with genAI-driven momentum within the Medical Instruments industry.

Zacks Equity Research

Wall Street Analysts See a 31.74% Upside in Integer (ITGR): Can the Stock Really Move This High?

by Zacks Equity Research

The mean of analysts' price targets for Integer (ITGR) points to a 31.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Zacks.com featured highlights StoneCo, CVS Health, Integer and USANA Health Sciences

by Zacks Equity Research

StoneCo, CVS Health, Integer and USANA Health Sciences stand out as low P/CF value plays with solid growth forecasts in a volatile market.

Sumit Singh headshot

4 Value Stocks Every Investor Should Hold in Volatile Times

by Sumit Singh

StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.

Zacks Equity Research

ITGR or PEN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why Integer (ITGR) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Sumit Singh headshot

4 Value Stocks to Shield Amid Labor Market and Trade Worries

by Sumit Singh

CVS, ITGR, ASB and FNB emerge as value picks amid trade tensions and labor market concerns, thanks to strong cash flow metrics.

Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?

by Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?

Zacks Equity Research

Why Integer (ITGR) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Integer Holdings Q2 Earnings Miss Estimates, Revenues Up Y/Y

by Zacks Equity Research

ITGR posts strong second-quarter revenue growth, but EPS misses estimate despite solid segment momentum.

Zacks Equity Research

Integer (ITGR) Q2 Earnings Lag Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of -1.27% and +2.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ECL Unveils ReadyDose Cleaning Program for Southeast Asian Restaurants

by Zacks Equity Research

Ecolab rolls out ReadyDose, a tablet-based cleaning solution to help Southeast Asian restaurants cut waste and boost hygiene.

Zacks Equity Research

ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval

by Zacks Equity Research

Intuitive Surgical wins FDA nod for its Vessel Sealer Curved, boosting the da Vinci system's precision and multifunctional capabilities.

Zacks Equity Research

ITGR or PEN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ITGR vs. PEN: Which Stock Is the Better Value Option?

Zacks Equity Research

InspireMD Launches CGuard Prime Carotid Stent System in the U.S.

by Zacks Equity Research

NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.

Zacks Equity Research

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

by Zacks Equity Research

FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.

Zacks Equity Research

AMN Stock Gains Post Latest Deals With symplr to Boost Operations

by Zacks Equity Research

AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.

Zacks Equity Research

Here's Why You Should Add PacBio Stock to Your Portfolio Now

by Zacks Equity Research

PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.

Zacks Equity Research

Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial

by Zacks Equity Research

STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.

Zacks Equity Research

Why Integer (ITGR) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Equity Research

Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark

by Zacks Equity Research

ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet.

Zacks Equity Research

Here's Why You Should Add HealthEquity Stock to Your Portfolio Now

by Zacks Equity Research

HQY's sustained strength in HSAs raises optimism about the stock.